Brief: Biomarin Announces Board Leadership Transition
21/04/2026 21:43
April 21 (Reuters) - Biomarin Pharmaceutical Inc BMRN.O: BIOMARIN ANNOUNCES BOARD LEADERSHIP TRANSITION BIOMARIN PHARMACEUTICAL INC - APPOINTS IAN T. CLARK AS CHAIR OF BOARD, EFFECTIVE AFTER JUNE 2, 2026 ANNUAL MEETING BIOMARIN PHARMACEUTICAL INC - RICHARD A. MEIER TO RETIRE FROM BOARD AFTER ANNUAL MEETING Source text: ID:nPn9v4cyva Further company coverage: BMRN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioMarin Pharmaceutical
See all newsUS RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
Brief: Biomarin Pharmaceutical Expects Q3 2026 Pre-Tax Charges Of $283 Million For Bought Ipr&D Expense
Brief: Biomarin Appoints Cara Bauer As Chief People Officer
Brief: Biomarin Pharmaceutical Enters Settlement And License Agreement With Ascendis Pharma On Sept 24, 2026
U.S. STOCKS ON THE MOVE-GitLab, California utilities, Herbalife